NADPH oxidase 4 mediates upregulation of type 4 phosphodiesterases in human endothelial cells

NADPH oxidase 1 mediates upregulation of thromboxane A2 synthase in human vascular smooth muscle cells: Inhibition with iloprost

(2011) Saima Muzaffar et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Role for TNF in atherosclerosis? Lessons from autoimmune disease

(2009) Gayle E. McKellar et al.   Nature Reviews Cardiology

Superoxide from NADPH oxidase upregulates type 5 phosphodiesterase in human vascular smooth muscle cells: inhibition with iloprost and NONOate

(2008) S Muzaffar et al.   BRITISH JOURNAL OF PHARMACOLOGY

PDE4 inhibitors: current status

(2008) D Spina   BRITISH JOURNAL OF PHARMACOLOGY

Thromboxane A2: Physiology/pathophysiology, cellular signal transduction and pharmacology

(2008) Norimichi Nakahata   PHARMACOLOGY & THERAPEUTICS

Acute inhibition of superoxide formation and Rac1 activation by nitric oxide and iloprost in human vascular smooth muscle cells in response to the thromboxane A2 analogue, U46619

(2008) S. Muzaffar et al.   PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS